secwatch.observer — SEC 8-K summary
======================================

Issuer:     EVOME MEDICAL TECHNOLOGIES INC. (—)
CIK:        0001617765
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001062993-23-013870
Event type: leadership
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Salona Global terminates CEO Luke Faulstick, appoints Michael Seckler as interim CEO
--------------------------------------------------------------------------------

- Luke Faulstick terminated as President and CEO effective June 13, 2023; remains on the board.
- Michael Seckler appointed Interim CEO; previously senior executive at Ferring/FerGene.
- Joseph Martinez terminated as SVP Legal, General Counsel, Secretary; available as hourly consultant.
- Company prioritizing cash flow from operations and debt restructuring per chairman.
- Seckler receives $100k salary, up to $200k variable comp, and 250,000 options at CAD$0.25.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1617765/000106299323013870/0001062993-23-013870-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1617765/000106299323013870/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-23-013870

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer